Suppr超能文献

源于大、小唾液腺的腺样囊性癌。

Adenoid cystic carcinoma of major and minor salivary gland origin.

作者信息

Matsuba H M, Thawley S E, Simpson J R, Levine L A, Mauney M

出版信息

Laryngoscope. 1984 Oct;94(10):1316-8. doi: 10.1288/00005537-198410000-00011.

Abstract

The records of 76 patients with adenoid cystic carcinoma of major and minor salivary gland origin seen at the Washington University Medical Center from 1963-1980 were reviewed to determine factors involved in local control, development of distant metastasis, and survival. Twenty-four (32%) patients were initially treated with surgery alone, 36 (47%) with combined surgery and irradiation, and 16 (21%) with irradiation alone. Local control after treatment was determined for all patients and was analyzed with respect to extent of surgery and dose of irradiation. Of 75 patients evaluable for local control, 30 (40%) failed with a median time of less than 5 years. There was no significant difference for patients treated vigorously for local recurrences after surgery. Patients who had a complete surgical resection (i.e., negative margins) survived significantly longer than patients treated by incomplete resection or biopsy alone followed by irradiation. Distant metastases developed in 50% of patients regardless of local control. Median survival after development of distant metastases was 40 months. There was no difference between major and minor gland sources for development of metastases. Lymph node involvement was rare. Our data indicate that complete and radical surgery results in the best survival. Combined modality therapy with surgery and irradiation optimizes the control of local disease. However, since distant metastases develop in spite of local control, in most instances we cannot recommend mutilating surgery for this disease entity.

摘要

对1963年至1980年间在华盛顿大学医学中心就诊的76例源于大、小唾液腺的腺样囊性癌患者的记录进行了回顾,以确定与局部控制、远处转移的发生及生存相关的因素。24例(32%)患者最初仅接受手术治疗,36例(47%)接受手术联合放疗,16例(21%)仅接受放疗。确定了所有患者治疗后的局部控制情况,并根据手术范围和放疗剂量进行了分析。在可评估局部控制情况的75例患者中,30例(40%)失败,中位时间不到5年。对术后局部复发进行积极治疗的患者之间无显著差异。接受完整手术切除(即切缘阴性)的患者比仅接受不完全切除或活检后放疗的患者生存时间显著更长。无论局部控制情况如何,50%的患者发生远处转移。远处转移发生后的中位生存期为40个月。大、小唾液腺来源在转移发生方面无差异。淋巴结受累情况罕见。我们的数据表明,完整且根治性的手术可带来最佳生存。手术联合放疗的综合治疗方式可优化局部疾病的控制。然而,由于尽管有局部控制仍会发生远处转移,在大多数情况下,我们不建议对这种疾病实体进行致残性手术。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验